EDAP TMS S.A. (NasdaqGM: FOCL)
Health Care · Health Care Equipment & Supplies · FR
$4.34
+3.46% today · +100.5% 1Y
EDAP TMS S.A. (NasdaqGM: FOCL) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $192.54M and employs 289 people.
Over the last twelve months the share price has gained 100.5%, trading between 1.75 and 6.40.
Tweenvest scores EDAP TMS S.A. across four factors: quality 55/100, value 59/100, growth 58/100. Its strongest factor is value.
FOCL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $192.54M
- Revenue (TTM)
- $79.31M
- P/E
- —
- EPS
- -1.04
- Dividend yield
- —
- Beta (5Y)
- -0.05
- 52-week high
- $6.40
- 52-week low
- $1.75
- Avg volume (3M)
- —
- Shares outstanding
- 45.95M
- Employees
- 289
- Next earnings
- —
About EDAP TMS S.A.
EDAP TMS S.A. operates as a holding company, with its subsidiary primarily focused on the innovation, manufacturing, and distribution of advanced, minimally invasive medical devices engineered to address urological conditions. The company's activities are organized into two principal divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS). The HIFU segment is dedicated to the creation, production, and commercialization of devices that employ HIFU technology for the precise, non-surgical elimination of certain localized tumors. In contrast, the UDS division concentrates on the entire lifecycle—from development and marketing to manufacturing and servicing—of medical instruments used for the minimally invasive diagnosis and treatment of various urological disorders, particularly urinary stones and other related clinical indications. This enterprise was founded on December 3, 1979, and its corporate headquarters are located in Vaulx-en-Velin, France.
- ISIN
- US2683111072
- Founded
- 1979
- Listed since
- Aug 1, 1997
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Pro-Dex, Inc.NasdaqCM: PDEX | $200.18M | $62.40 | -0.14% |
| RxSight, Inc.NasdaqGM: RXST | $200.06M | $4.61 | -4.26% |
| USBC, Inc.NYSEAM: USBC | $197.91M | $0.49 | -3.80% |
| Vieworks Co., Ltd.KOSDAQ: A100120 | $194.99M | ₩30,300.00 | +5.39% |
| Onward Medical N.V.ENXTBR: ONWD | $192.29M | €2.47 | 0.00% |
| Value Added Technology Co., Ltd.KOSDAQ: A043150 | $188.61M | ₩17,070.00 | -3.99% |
| AOTI, Inc.AIM: AOTI | $186.49M | £1.33 | 0.00% |
| Next Biomedical Co.,Ltd.KOSDAQ: A389650 | $182.86M | ₩29,700.00 | -6.46% |
Figures last refreshed Oct 11, 2026.